Boris A. Van Doorn

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Safe discharge on the second postoperative day after major colorectal surgery: a decision-making strategy based on quantitative serological data.

Safe discharge on the second postoperative day after major colorectal surgery: a decision-making strategy based on quantitative serological data.

Journal: Techniques in coloproctology
Published: September 03, 2025

Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluation.

Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluation.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 30, 2025

Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study.

Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study.

Journal: Allergy
Published: May 17, 2024

Prospective practice survey of management of cetuximab-related skin reactions.

Prospective practice survey of management of cetuximab-related skin reactions.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: September 08, 2020

A woman with bumps in the eyebrows

A woman with bumps in the eyebrows

Journal: Nederlands tijdschrift voor geneeskunde
Published: May 13, 2020

Mobile e-diary application facilitates the monitoring of patient-reported outcomes and a high treatment adherence for clinical trials in dermatology.

Mobile e-diary application facilitates the monitoring of patient-reported outcomes and a high treatment adherence for clinical trials in dermatology.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: March 18, 2019

Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers.

Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: August 23, 2018

A systematic literature review of the human skin microbiome as biomarker for dermatological drug development.

A systematic literature review of the human skin microbiome as biomarker for dermatological drug development.

Journal: British journal of clinical pharmacology
Published: January 24, 2018

A man with severe skin rash

A man with severe skin rash

Journal: Nederlands tijdschrift voor geneeskunde
Published: January 13, 2018

Non-invasive anaesthetic methods for dermatological laser procedures: a systematic review.

Non-invasive anaesthetic methods for dermatological laser procedures: a systematic review.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: October 26, 2016

Lentigo maligna - anatomic location as a potential risk factor for recurrences after non-surgical treatment.

Lentigo maligna - anatomic location as a potential risk factor for recurrences after non-surgical treatment.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 26, 2016

A two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod: excellent cosmesis, but frequent recurrences on the nose.

A two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod: excellent cosmesis, but frequent recurrences on the nose.

Journal: The British journal of dermatology
Published: December 01, 2015
Showing 1-12 of 24

Last Updated: 09/26/2026